Beauty Health Co SKIN.OQ SKIN.O is expected to show a fall in quarterly revenue when it reports results on March 12 for the period ending December 31 2024
The Long Beach California-based company is expected to report a 20.1% decrease in revenue to $77.39 million from $96.8 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
LSEG's mean analyst estimate for Beauty Health Co is for a loss of 11 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 6 "hold" and 3 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Beauty Health Co is $1.88, above its last closing price of $1.30.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.12
-0.11
-0.09
Beat
19.2
Jun. 30 2024
-0.03
-0.05
0.00
Beat
102
Mar. 31 2024
-0.13
-0.14
-0.01
Beat
92.7
Dec. 31 2023
-0.08
-0.08
-0.07
Beat
7.4
Sep. 30 2023
0.09
0.09
0.10
Beat
17.6
Jun. 30 2023
0.05
0.06
0.17
Beat
209.1
Mar. 31 2023
-0.02
-0.02
-0.04
Missed
-80
Dec. 31 2022
0.04
0.04
0.05
Beat
32.4
This summary was machine generated March 10 at 20:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)